INTRODUCTION {#S1}
============

Immunoglobulin A (IgA) predominates in the intestinal tract and is crucial for modulation of commensal microbiota and defense against enteric pathogens.^[@R1],[@R2]^ The absence of mucosal IgA renders newborns particularly susceptible to intestinal infections. Initially, newborns and infants may acquire protection through passive transfer of maternal IgG via the placenta and secretory IgA in maternal breast milk, but they must generate their own mucosal IgA to maintain intestinal defense after weaning.

IgA-secreting cells in the infant intestinal tract are absent at birth but increase with age.^[@R3]--[@R5]^ The development of these IgA-producing cells requires recruitment of B cells to organized lymphoid structures within the mucosa, class switch recombination (CSR) from IgM to IgA and differentiation to antibody-secreting plasma cells. In mice and humans, intestinal IgA CSR in naïve B cells occurs classically through T cell- dependent (TD) mechanisms within gut-associated lymphoid tissue such as Peyer's patches and isolated lymphoid follicles (ILFs).^[@R6]--[@R8]^ In these inductive sites, CSR to IgA follows engagement of CD40 on B cells with CD40 ligand (CD40L) from CD4^+^ helper T cells and upregulation of the CSR-inducing enzyme activation-induced cytidine deaminase (AID) in B cells.^[@R6]^ Additionally, helper T cells can provide non-cognate help by secreting immunomodulating cytokines, such as TGFβ, IL-10 and IL-6 that augment B cell CSR, differentiation and survival, respectively.^[@R6],[@R9]^.

Alternatively, T cell-independent (TI) mechanisms of IgA CSR in the intestinal tract of mice, and possibly of humans, are mediated by interactions of B cells with CD40L-like molecules, a proliferation-inducing ligand (APRIL) and B cell-activating factor (BAFF).^[@R10],[@R11]^ These molecules are produced locally by cells within the intestinal tract, including epithelial cells, dendritic cells, macrophages and neutrophils^[@R12]^ and directly engage surface receptors on B cells (BCMA, TACI, BAFF-R) to induce the upregulation of AID and IgA class switching.^[@R13],[@R14]^ Indeed, mice deficient in APRIL and humans lacking a receptor for APRIL (TACI; transmembrane activator and calcium-modulator and cyclophilin ligand interactor), both exhibit substantially reduced IgA production.^[@R15],[@R16]^ However, mice lacking T cells, CD4 or CD40L still develop relatively normal intestinal IgA responses,^[@R10],[@R11],[@R17]^ highlighting the importance of TI, rather than TD, mechanisms of CSR in intestinal IgA development.

The sequence of and specific requirements for mucosal IgA development have been elegantly characterized in mouse models but mice and humans show anatomical and cellular differences in their IgA induction systems.^[@R18]^ Mice have a single IgA isotype and require TGFβ signaling for IgA class switching.^[@R19]^ Unlike mice, humans have two subclasses of IgA, IgA1 and IgA2, and do not require TGFβ stimulation for IgA class switching.^[@R13]^ Additionally, human newborns have isolated lymphoid follicles (ILFs), a site of IgA CSR, in the intestinal tract at birth whereas newborn mice only develop ILFs in response to bacterial exposure after birth. Given the multiple developmental differences in IgA CSR between mice and humans, the requirements for the induction of IgA plasma cells in the human newborn may differ from those observed in newborn mouse models, among which TI CSR appears to predominate.

Although the human adult intestinal tract expresses all the components necessary for both TD and TI class switching,^[@R12]^ the contributions of TD and/or TI CSR in the generation of intestinal IgA plasma cells in human infants is not well characterized. Defining the ontogeny of IgA plasma cells from birth and the contributions of TD and TI IgA class switch factors within the human infant intestinal tract will facilitate identification of potential targets for enhancing early infant IgA responses to enteric pathogens and mucosal vaccines. Thus, we characterized the localization and densities of intestinal plasma cells and their isotype distribution in the first two years of life. We further determined the expression of factors in the intestine required for class switch recombination (AID) and mucosal TD (CD4^+^ T cells, CD40L, CD40) and TI (APRIL, BAFF, TACI, BMCA, BAFF-R) class switching in the human infant. We show that TI class switch factors APRIL and BCMA, but not TD factors, have limited expression within ILFs during the first month of life but increase over time, in association with the progressive accumulation of IgA plasma cells in the human infant intestinal tract.

RESULTS {#S2}
=======

cIgA^+^ plasma cells reach adult densities after those with cIgM^+^ or cIgG^+^ in the infant intestinal tract {#S3}
-------------------------------------------------------------------------------------------------------------

In the adult intestinal tract, B cells are localized to inductive sites, such as isolated lymphoid follicles (ILFs) as well as non-inductive isolated lymphoid aggregates (ILAs), whereas plasma cells are found in the effector site, the lamina propria.^[@R20]^ Consistent with this study, we found infant CD20^+^ B cells were only detected within or in very close proximity to ILFs and ILAs, but not within the lamina propria or among epithelial cells. Conversely, plasma cells, when present, were predominantly in the lamina propria ([Supplemental Figure 1](#SD1){ref-type="supplementary-material"}). The density of infant CD138^+^ plasma cells in the lamina propria increased progressively over the first two years of life ([Figure 1a](#F1){ref-type="fig"}), with no plasma cells detectable until after one week of age. Plasma cells were present in all infants greater than 2 months of age (range: 85 -- 1566 cells/mm^2^). Although plasma cell densities increased significantly by 1--2 months and remained higher than 0--1 month densities throughout the two years, they did not approach values observed in adults until after 6 months. Hence, although localization of plasma cells mirrored that of adults, the acquisition of intestinal plasma cells in infants is largely delayed until after 1 month of age.

Adult intestinal plasma cells primarily express IgA. Because we observed increasing plasma cell densities over time, we next investigated plasma cell isotypes (cytoplasmic IgA (cIgA^+^), cIgM^+^ and cIgG^+^) in the infant intestinal tract from birth to two years by immunofluorescence. Similar to CD138^+^ plasma cells densities, cIg^+^ cells increased over time in the infant lamina propria, accounting for 28% (range: 17 -- 41%) of total lamina propria cells by two years of age ([Figure 1b](#F1){ref-type="fig"}, data not shown). However, the distribution of individual isotypes varied over time. cIgA^+^ cell densities most closely mirrored those of CD138^+^ cells ([Figure 1c](#F1){ref-type="fig"}), both of which steadily increased over time.

In infant sera, IgM is produced earlier in life than IgA.^[@R21]^ Consistent with these results in the infant systemic compartment, the densities of intestinal cIgM^+^ cells attained adult levels earlier than did cIgA^+^ cells and even exceeded adult densities between 6--24 months (218.5±42.8 vs 120.3±26.4 cells/mm^2^, mean±SEM) ([Figure 1c,d](#F1){ref-type="fig"}). Additionally, the mean density of cIgM^+^ cells was higher between 0--1 month, albeit marginally, than that of cIgA^+^ cells (45.8±24.7 and 38.5±15.6 cells/mm^2^, respectively). Compared with adults, cIgM^+^ cells represented a larger proportion of intestinal plasma cells throughout the first two years of life ([Figure 1f](#F1){ref-type="fig"}). cIgG^+^ cells were present at very low frequencies both throughout the first two years and in adults ([Figure 1e](#F1){ref-type="fig"}). Nevertheless, by 2 months, both the densities and proportions of cIgA^+^ cells exceeded those of both cIgM^+^ and cIgG^+^ cells and remained the predominant isotype thereafter ([Figure 1f](#F1){ref-type="fig"}).

To confirm that the cIgA^+^ cells observed in the infant tissues were indeed plasma cells (Ki67^−^) and not recently migrated plasmablasts (Ki67^+^), we stained for the proliferation marker Ki67 by immunofluorescence. No cIgA^+^ cells in the infant lamina propria had detectable nuclear Ki67^+^ staining ([Figure 1g](#F1){ref-type="fig"}), confirming that cIgA^+^ cells are indeed terminally differentiated plasma cells. Of note, Ki67^+^ staining was only detectable within isolated lymphoid follicles and the epithelium in the infant intestinal tract.

AID expression, localized to isolated lymphoid follicles, is expressed prior to IgA plasma cell development {#S4}
-----------------------------------------------------------------------------------------------------------

Because B cells must first undergo class switch recombination (CSR) to become IgA^+^ plasma cells, we next determined the localization of AID mRNA, an essential enzyme in B cell CSR, in the infant intestinal tract. Previous research in the human intestine suggests that AID expression is localized exclusively to organized lymphoid structures (i.e. ILFs) and is not detectable within non-organized lymphoid structures (i.e. ILAs) or the lamina propria.^[@R12],[@R22],[@R23]^ Thus, we compared AID and CD20 mRNA expression in infants ranging from 0--6 months of age with qPCR. We divided the infant samples into three histologic groups: 1) those containing ILFs (ILF-containing, termed ILF-C), 2) those containing B cell ILAs but not ILFs (ILA-containing, termed ILA-C) and 3) those containing lamina propria but not ILFs or ILAs (lamina propria containing, termed LP-C). CD20 mRNA expression was higher in ILF-C and ILA-C samples than LP-C samples, which showed very little if any CD20 expression ([Figure 2a](#F2){ref-type="fig"}), consistent with the localization of CD20 staining ([Supplemental Figure 1](#SD1){ref-type="supplementary-material"}). Similarly, ILF-C samples showed significantly higher AID mRNA expression than LP-C samples ([Figure 2b](#F2){ref-type="fig"}). Indeed, expression of AID was virtually absent in all LP-C samples and present in only 2 of 10 ILA-C samples.

Consistent with our observation that the development of cIgA^+^ cells was delayed compared with cIgM^+^ cells in the lamina propria of young infants, we hypothesized that AID expression in infant B cells would be reduced in the first months of life. However, we found that AID expression, when normalized either to GAPDH or CD20, was similar between samples obtained at less than or greater than one month of age ([Figure 2c](#F2){ref-type="fig"}, data not shown). Surprisingly, AID was expressed in ILF-C samples prior to one month, even though very few IgA plasma cells were present in this time period. Therefore, AID expression, which is present before one month of age, does not appear to be restricting the generation of infant intestinal IgA plasma cells.

T cell-dependent factors are present in the infant intestinal tract prior to IgA plasma cell development {#S5}
--------------------------------------------------------------------------------------------------------

Although AID is required for CSR, its expression is not sufficient to support the generation of IgA plasma cells. Additional factors are utilized by both T cell-dependent (TD) and T cell-independent (TI) mechanisms to promote CSR to IgA and downstream IgA plasma cell development. To identify the factors involved in these pathways that could contribute to IgA CSR in young infants, we determined the localization and the temporal development of TD factors (CD4^+^ T cells, CD40L and CD40) in the infant intestinal tract. CD4^+^ T cells were present in the earliest samples within the lamina propria and ILFs, as determined by IHC ([Figure 3a](#F3){ref-type="fig"}, data not shown). However, unlike IgA plasma cells, CD4^+^ T cells in the lamina propria did not increase in density with infant age. Similarly, CD4 mRNA expression was detectable at comparable levels in LP-C and ILF-C samples at birth and did not change with age ([Figure 3b,c](#F3){ref-type="fig"}). CD40L and CD40 were expressed in LP-C and ILF-C samples and both were higher in ILF-C samples ([Figure 3b,c](#F3){ref-type="fig"}). Temporally, CD40L and CD40 were expressed prior to one month and did not change over time in ILF-C or LP-C samples, although CD40 expression did trend toward higher expression after one month in ILF-C tissues.

We additionally determined whether specific cytokines important for IgA CSR (TGFβ), B cell differentiation (interleukin 10 (IL-10)) and plasma cells survival (IL-6) were expressed in the infant intestinal tract. TGFβ, IL-10 and IL-6 were all expressed in LP-C and ILF-C samples and showed no change in expression level with age (data not shown). Thus, although IgA development is delayed until after one month of age, B cell and T cell factors essential for CD40-CD40L mediated CSR, B cell differentiation and plasma cell survival are already present early in the infant intestinal tract before IgA plasma cells.

T cell-independent factor APRIL and its receptors TACI and BCMA have significantly reduced expression in the first month of life {#S6}
--------------------------------------------------------------------------------------------------------------------------------

Given the early expression of TD components, we hypothesized that factors involved in TI CSR may instead be absent or reduced in the infant intestinal tract during the first months of life. Thus, we determined the localization and expression of APRIL, BAFF and their receptors (TACI, BCMA, BAFF-R) by qPCR in samples between 0--6 months. APRIL and BAFF were expressed both in LP-C and ILF-C samples at all ages. However, levels of APRIL, but not BAFF, increased significantly after one month within ILF-C samples ([Figure 4a](#F4){ref-type="fig"}). Of note, APRIL and BAFF were expressed at consistent levels within LP-C samples over time, indicating their alternative role in plasma cell survival within the intestinal lamina propria is likely preserved during early infancy.

Unlike APRIL and BAFF expression, TACI was virtually absent in all LP-C samples but present in ILF-C samples ([Figure 4b](#F4){ref-type="fig"}), consistent with TACI being expressed by B cells and not plasma cells. On the other hand, BCMA, which can be found on both B cells and plasma cells,^[@R24]^ was expressed in both LP-C and ILF-C samples. Similar to APRIL, both TACI and BCMA expression increased significantly after one month in ILF-C samples. BAFF-R, an additional receptor for BAFF, showed no significant changes over time, although its expression did appear reduced prior to one month of age. Thus, decreased expression of APRIL and its receptors BCMA and TACI within ILFs may impair IgA plasma cell development in the infant intestinal tract during the first month of life.

Expression of APRIL and its receptor BCMA within isolated lymphoid follicles correlates with increasing IgA plasma cell densities in the infant intestinal tract {#S7}
----------------------------------------------------------------------------------------------------------------------------------------------------------------

In order to identify potential mediators of IgA plasma cell development, we determined the relationships between plasma cell densities and ILF-associated expression of TD and TI CSR factors in the infant intestinal tract utilizing a multiple comparison approach (see Methods). We found our data divided into two clusters; cluster one included IgA, CD138, age, APRIL and BCMA and cluster two included CD20, CD40, TACI and BAFF-R ([Supplemental Figure 2](#SD1){ref-type="supplementary-material"}). Indeed, APRIL and BCMA expression within ILF-C samples strongly correlated with IgA plasma cell densities ([Figure 5a](#F5){ref-type="fig"}), whereas TACI and BAFF-R expression correlated with B cell-specific CD20 expression ([Figure 5b](#F5){ref-type="fig"}). Although TACI expression did not directly correlate with cIgA^+^ cell densities, samples lacking TACI expression exhibited no detectable cIgA^+^ cells (data not shown). Thus, the interaction between APRIL and its receptors TACI and BCMA on B cells may play a critical role in IgA plasma cell induction during early infancy.

Since APRIL expression within ILFs most strongly correlated with infant IgA plasma cell development, we determined the presence and localization of APRIL^+^ cells in comparison to B cell localization within ILFs in infant intestinal tract by immunohistochemistry. Soluble APRIL and APRIL^+^ cells were preferentially detectable within the B cell area of ILFs in the infant intestinal tract by IHC ([Figure 5c,d](#F5){ref-type="fig"}), highlighting that APRIL-producing cells are present and in contact with B cells in infant ILFs. Additionally, cells in the ILF epithelial dome stained more intensely for APRIL than adjacent epithelial cells ([Figure 5e](#F5){ref-type="fig"}). Consistent with our mRNA expression data, APRIL^+^ cells were also identified within the lamina propria ([Figure 5f](#F5){ref-type="fig"}). Therefore, the interaction between APRIL-producing cells and B cells expressing APRIL-specific receptors (TACI, BCMA) within ILFs in the infant intestinal tract may be facilitating the induction of intestinal IgA during early infancy.

Preterm infants have fewer intestinal plasma cells than full term infants, with reductions in both IgA plasma cells and APRIL expression {#S8}
----------------------------------------------------------------------------------------------------------------------------------------

Breastfeeding and gestational age (GA) can influence infant immune development and thus could be affecting the induction of intestinal IgA plasma cells. We were unable to evaluate the effect of breastfeeding on IgA development in this cohort as the majority of these infants were either exclusively breastfed or mixed fed at the time of biopsy. However, we had sufficient numbers of preterm (n= 6, less than 37 weeks GA) and full term infants (n=8, greater than 37 weeks GA) samples ranging between 1--6 months of age (median age: 2.11) to compare IgA plasma cell development. Age range, gender and breastfeeding methods were similar between the two groups, although preterm infants did have a higher incidence of caesarian section delivery ([Supplemental Table 1](#SD1){ref-type="supplementary-material"}).

Preterm infants exhibited lower CD138^+^ plasma cell densities compared with full term infants ([Figure 6a](#F6){ref-type="fig"}). cIgA^+^ cell densities showed a similar trend (568 versus 1,147 median cells/mm^2^). Conversely, the densities of cIgM^+^ cells were comparable in both groups, as were CD4^+^ T cell densities in the lamina propria (data not shown).

BCMA expression and subsequent IgA production after *in vitro* APRIL stimulation is reduced in peripheral B cells from preterm infants.^[@R25]^ Thus, we additionally determined APRIL and BCMA expression in a subsets of preterm (n=3) and full term (n=3) infants. Although there was no difference in BCMA expression, APRIL expression was reduced in preterm samples compared to full term samples ([Figure 6b](#F6){ref-type="fig"}), further implicating APRIL as a key mediator of early IgA plasma cell induction in the infant intestinal tract.

DISCUSSION {#S9}
==========

Delayed development of mucosal IgA production may predispose young infants to infectious diseases, particularly when they are premature or in the absence of breastfeeding. We show limited generation of intestinal IgA plasma cell during the first month of life in human infants, approaching but not attaining adult levels by two years. In contrast, the lower densities of IgG and IgM cells parallel adult levels by 2 months of age and even surpass adult levels by two years, suggesting IgA class switching is hindered during early infancy.

AID plays a critical role in IgA class switching as well as antibody somatic hypermutation. However, AID expression, almost exclusively detected within ILFs in the infant intestinal tract, was found prior to the development of IgA plasma cells. These data are consistent with a previous study that showed similar AID expression in newborns and adult peripheral B cells^[@R26]^ and indicate that the ability of infant B cells to undergo AID-mediated CSR is not restricting intestinal IgA development. Conversely, studies on infant SHM demonstrate very limited mutations in circulating IgA^+^ B cells from young infants compared with adults.^[@R27]^ Whether AID-mediated somatic hypermutation is observed in the IgA plasma cell population during early infancy and whether mutations in IgA advance more rapidly in the infant intestine than the periphery is currently under investigation.

Within organized inductive tissues, CSR is additionally mediated by T cell-dependent (TD) and/or T cell-independent (TI) mechanisms. Variables that influence TD CSR, including the presence of CD4^+^ T cells and expression of the T cell activation marker CD40 ligand and its receptor CD40, were detectable from the earliest times of life and did not increase over time, nor were they associated with the accumulation of cIgA^+^ plasma cells. CD4^+^ T cells can also influence CSR via non-cognate interaction by the secretion of soluble factors, such as TGFβ, IL-6 and IL-10. Expression of all of these cytokines was detectable in the infant intestinal tract prior to one month. Thus, neither cognate nor non-cognate CD4^+^ T cells interaction appear limiting in the generation of IgA plasma cells during early infancy.

TI responses in the intestinal tract of mice are essential for the development of IgA plasma cells and are mediated in part by interactions between TACI and APRIL. Indeed, newborn mice have reduced TACI expression on B cells compared with adults, leading to poor responsiveness to APRIL stimulation.^[@R28]^ Similarly, in the human infant intestinal tract, expression of TACI and APRIL within ILFs was low or absent during the first month of life. Although infants lacking TACI expression also showed very few, if any, IgA plasma cells within the lamina propria, the expression of APRIL and its other receptor BCMA, but not TACI, strongly correlated with increasing densities of intestinal IgA plasma cells. These data suggest that TACI and BCMA expression on intestinal B cells as well as increasing expression of their ligand APRIL within ILFs are important for the initial induction of IgA class switching and the accumulation of infant intestinal plasma cells.

APRIL plays a central role in IgA CSR, B cell differentiation and long-term plasma cell survival.^[@R29],[@R30]^ Thus, the limited expression of APRIL observed prior to one month could be influencing multiple steps in the development of IgA plasma cells. However, APRIL and IL-6, another important plasma cell survival factor, are expressed consistently in the lamina propria throughout infancy. APRIL^+^ cells within the lamina propria are also detectable prior to one month of age. Therefore, decreased plasma cell survival within the lamina propria is unlikely the mechanism for limited IgA plasma cell generation during the first month of life. Although we cannot fully rule out reduced B cell differentiation as a cause of limited generation of IgA plasma cells, no accumulation of class switched IgA^+^ B cells within ILFs was observed during early infancy (data not shown) and all infant IgA plasma cells within the lamina propria appeared terminally differentiated, consistent with adult studies.^[@R22],[@R30]^ Taken together, these data indicate that an essential function of APRIL specifically within ILFs in the young infant intestinal tract is most likely to promote IgA CSR.

It has been well established in humans and mice that APRIL's interaction with TACI can induce IgA CSR. However, the importance of BCMA in this process is still unclear. BCMA, expressed at the highest levels on plasmablasts, is detectable on a variety of B cell subsets, including mature naïve and transitional B cells in cord blood.^[@R24]^ Moreover, BCMA has been demonstrated to have a significant, although not essential, function in IgA production in response to APRIL stimulation in mice.^[@R31]^ We found BCMA expression within infant ILFs but not the LP correlated with increasing IgA plasma cell densities, implicating a potential role for BCMA in the induction of IgA CSR as well as plasma cell survival early in life. Due to the limited tissue available in our ILF-containing samples, we were unable to perform IHC staining for BCMA within ILFs. Determining the specific cell types that express BCMA and APRIL within infant ILFs and whether these cells are reduced during early infancy warrants further examination. Additionally, investigating the functional role of BCMA in APRIL-induced IgA CSR in humans will provide better insight into the mechanisms of intestinal IgA induction during early infancy.

In human infants, mucosal IgA development has been linked with microbial colonization of the intestinal tract.^[@R32],[@R33]^ Similarly, IgA plasma cells arise in germ-free and newborn mice *in vivo* upon intestinal colonization with commensal bacteria.^[@R10],[@R34]^ The mechanisms for microbial-induced IgA is thought to occur primarily through TI mechanisms. In this regard, stimulation of mouse B cells *in vitro* with a bacterial DNA surrogate, CpG, induces IgA production in response to APRIL by increasing B cell expression of TACI.^[@R28]^ Moreover, CpG stimulation of human B cells causes an upregulation of both TACI and BCMA expression,^[@R24],[@R35]^ implying BCMA could influence IgA CSR within the infant intestinal tract upon microbial colonization.

In infants, normal intestinal colonization can be affected by a variety of clinical factors including premature birth.^[@R36],[@R37]^ Preterm infants not only have altered intestinal bacterial colonization but, immunologically, exhibit lower expression of BCMA on circulating B cells compared with full term infants.^[@R25]^ Thus, prematurity may cause impaired generation of intestinal IgA plasma cells in infants. Indeed, we found that preterm infants had lower frequencies of intestinal plasma cells than full term infants, with reduced densities of IgA but not IgM plasma cells. Preterm infants additionally had reduced expression of APRIL within the intestinal tract. Contrary to results from infant peripheral B cells, we found no difference in intestinal BCMA expression between preterm and full term infants, likely resulting from the constant exposure of intestinal, but not peripheral, B cells to microbial products. Thus, clinical factors, including premature birth and its related clinical consequences, may modulate intestinal IgA plasma cell development during early human infancy, potentially by modifying TI CSR mechanisms, and warrant further investigation in larger prospective cohorts.

In summary, in our comprehensive examinations of intestinal IgA plasma cell development during human infancy, we found that TI factors involved in IgA class switching, APRIL, TACI and BCMA, but not TD factors, were reduced within ILFs in the infant intestinal tract during the first months of life. Moreover, APRIL and BCMA expression both increased over time in association with the accumulation of IgA plasma cells. Similarly, preterm infants exhibited decreased intestinal IgA plasma cell densities and APRIL expression compared with full term infants. Thus, restricted IgA plasma cell generation in early human infancy may be due to blunted TI responses in intestinal B cells as well as reduced numbers of APRIL-producing cells, such as follicular dendritic cells, within inductive sites in the intestinal tract. Identifying mechanisms by which TI mediators can be upregulated in the intestine of young infants could provide potential targets for enhancing IgA responses to mucosal vaccines during early human infancy.

METHODS {#S10}
=======

Study Subjects {#S11}
--------------

### Infants {#S12}

Sixty formalin-fixed, paraffin-embedded (FFPE) rectal biopsies were obtained from children (age range: 0--24 months) undergoing clinical evaluation for Hirschsprung's disease at the Children's Hospital Colorado. All specimens collected showed normal histology without disease pathology as determined by formal review by a pediatric pathologist. Clinical data were obtained retrospectively by structured chart review ([Table 1](#T1){ref-type="table"}). Infant age groups did not differ by sex, gestational age, mode of delivery, antibiotic treatment, breastfeeding or reason for biopsy, but data were not available on all children. All specimens were collected with approval by the Colorado Multiple Institutional Review Board.

### Adults {#S13}

Sigmoid colon specimens (n=10) were obtained from patients undergoing elective abdominal surgery and represented otherwise discarded tissue from surgical excision. Those with a history of inflammatory bowel disease or receiving chemotherapy, radiation, or other immunosuppressive drugs were excluded. These samples were granted exempt research status by the Colorado Multiple Institutional Review Board. Not all specimens were used in every experiment. See figure legends for specific number for each experiment.

Immunohistochemistry {#S14}
--------------------

Tissues were deparaffinized and subjected to antigen retrieval in 10 mM sodium citrate (pH 6.0) at 95°C for 20 minutes. After blocking endogenous peroxidase activity, sections were double stained with rabbit anti-human antibodies for APRIL (1:600) and CD20 (1:300) (Abcam, Cambridge, MA) using the ImmPress staining system (Vector Labs, Burlingame, CA) according to manufacturer's protocol. After staining, sections were counterstained with methyl green. For negative controls, polyclonal rabbit isotype control (Abcam) was used at appropriate concentrations. Images were acquired on an upright Olympus BX51 microscope (Olympus America Inc., Central Valley, PA).

Immunofluorescence {#S15}
------------------

FFPE samples were deparaffinized and subjected to antigen retrieval by heating in 10 mM sodium citrate (pH 6.0). After blocking, tissue sections were stained with Dylight 649-labeled anti-human IgG, Dylight 549-labeled anti-human IgA and Dylight 488-labeled anti-human IgM (Jackson Immuno-Research Laboratories; West Grove, PA). For determining proliferation, tissues were permeabilized with 0.2% Triton X-100 prior to antigen retrieval and stained with FITC-labeled anti-human Ki67 (Abcam). Tonsil tissues were used as positive controls. Coverslips were applied using Vectashield with DAPI mounting media (Vector Labs). Images were acquired on a Leica DM5000B Fluorescent microscope (Leica Microsystems, Buffalo Grove, IL).

Image Analysis {#S16}
--------------

We determined the number of positively stained cells per mm^2^ in ≥4 40× fields for each sample. Photoshop CS2 (Adobe Systems Inc., San Jose, CA) was used for area determination and ImageJ (Rasband, W.S., ImageJ, NIH, Bethesda, MD, <http://imagej.nih.gov/ij/>, 1997--2012) for cell counting. An average of 0.066±0.016 mm^2^ (mean±SD) of lamina propria and 432.8±117.3 total non-epithelial cells (mean±SD) were analyzed per sample. CD4^+^ T cells were additionally distinguished from macrophages by morphology and intensity of staining.

Quantitative Reverse Transcription PCR (qPCR) {#S17}
---------------------------------------------

Within lymphoid aggregations in hematoxyin and eosin-stained sections, isolated lymphoid follicles (ILFs) were differentiated from isolated lymphoid aggregates (ILAs) by the presence or absence of germinal centers, respectively. ILFs and ILAs were further confirmed to contain B cells in CD20-stained sections. A subset of tissues from infants, ages 0.04 -- 5.71 months (median age: 1.57 months), were selected and divided into the following groups: those containing ILFs with or without ILAs (ILF-containing (ILF-C); n=9), those containing ILAs but no ILFs (ILA-containing (ILA-C); n=10), or those containing lamina propria with neither ILFs nor ILAs (lamina propria containing (LP-C); n=8). ILA-C samples were used as a control for AID mRNA expression, as they lack inductive site (i.e. ILFs) but still contain B cells.

Total RNA was extracted from 10 contiguous 5 μm slices from these samples using FFPE RNA Isolation Kit (Qiagen, Valencia, CA) as modified from Arzt *et.al*.^[@R38]^ Briefly, samples were deparaffinized twice in xylene for 3 minutes at 50°C then 10 seconds at room temperature and treated with proteinase at 80°C for 3 hours. Following final elution step in 20 μL RNA-free water, RNA was quantitated (Nanodrop ND-1000; Thermo Scientific, Wilmington, DE) and stored at −80°C. RNA extracted from unstimulated and phytohaemagglutinin (PHA)-stimulated PBMCs (5 ug/mL PHA, overnight) were used for positive controls. cDNA was prepared using Superscript II reverse transcriptase with random hexamer primers (Invitrogen, Carlsbad, CA) per manufacturer's protocol. Random hexamers were used to account for the fragmented nature of RNA extracted from FFPE tissue samples. We performed qPCR with 1 μL cDNA per reaction using Taqman gene expression assays (Applied Biosystems, Carlsbad, CA) per manufacturers protocol on a Biorad CFX96 real-time system (Biorad, Hercules, CA). The Taqman gene expression assays were: GAPDH (Hs03929097_g1), MS4A1 (CD20; Hs01096429_m1), AICDA (AID; Hs00757808_m1), CD4 (Hs01058409_g1), CD40LG (Hs00163934_m1), CD40 (Hs01002916_g1), TNFSF13 (APRIL; Hs00601664_g1), TNFLSF13B (BAFF; Hs00198106_m1), TNFRSF13B (TACI; Hs00963364_m1), TNFRSF17 (BCMA; Hs00171292_m1) and TNFRSF13C (BAFF-R; Hs00606874_g1). Gene expression was normalized to GAPDH, unless otherwise indicated. The relative expression of a target gene was calculated using the ΔCt method as 2^−\ (Ct\ target\ gene\ --\ Ct\ GAPDH)^.

Statistical Analysis {#S18}
--------------------

Data were analyzed with GraphPad Prism Version 6 for Mac OS X (La Jolla, CA) using either Kruskal-Wallis test with Dunn's multiple comparison post-test or Mann-Whitney U-test, as indicated. Chi squared tests were used to compare categorical variables from the clinical data. Utilizing an in-house R program ([www.explicet.org](www.explicet.org)), we created a multiple correlation matrix using Spearman's r comparing expression and density data. The heatmap.2 function of the R gplots package was used to render the correlation matrix (<http://cran.r-project.org/web/packages/gplots/index.html>). *P*-values less than .05 were considered statistically significant.
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![Development of plasma cells in the infant intestinal tract. **(a)** CD138^+^ cells/mm^2^ in the lamina propria of infant biopsies. Samples were separated into age groups (n = 16, 11, 16, 7, and 8 respectively from 0--1 mo to adult). Each dot represents the average number of CD138^+^ cells/mm^2^ in an individual sample. **(b)** Representative cytoplasmic IgM (green) and IgA (red) immunofluorescent staining of infant biopsies at 1, 2 and 12 months at 40x magnification. DAPI (nuclear) staining is in blue. **(c)** cIgA^+^, **(d)** cIgM^+^ and **(e)** cIgG^+^ cells/mm^2^ in lamina propria of infant biopsies (n = 21, 11, 16, 10, and 7 respectively from 0--1 mo to adult). Horizontal black lines indicate medians. \* *P* \< .05 compared to 0--1 month proportions. \# *P* \< .05, \# \# *P* \< .001, compared to adults. **(f)** Percent of cIgA^+^, cIgM^+^ and cIgG^+^ cells compared with total Ig^+^ cells. \*\*\* *P* \< .0001, comparing IgA and IgM percentages in each age group. Bars represent mean+SD. All *P*-values were determined using Kruskal-Wallis followed by Dunn's multiple comparison. NS=not significant. **(g)** Representative Ki67 (green) and IgA (red) staining in infant intestinal tract within isolated lymphoid follicles (ILF) and the lamina proria (LP). DAPI (nuclear) staining is in blue.](nihms515133f1){#F1}

![Localization and temporal expression of AID in the infant intestinal tract. **(a)** CD20 and **(b)** AID mRNA expression was determined by qPCR in infant biopsies (0--6 months of age). Tissue samples are divided into three groups: 1) those containing ILFs (ILF-C, n=9), 2) those containing ILAs but no ILFs (ILA-C, n=10) or 3) those containing neither ILAs nor ILFs (LP-C, n=8). \* *P* \< .05, \*\* *P* \< .01. *P*-values were determined using Kruskal-Wallis followed by Dunn's multiple comparison, medians shown. **(c)** AID expression normalized to CD20 in ILF-C samples less than (\< 1mo; n=3) or greater than one month (\> 1mo; n=6). Bars indicate median with min and max values. NS=not significant.](nihms515133f2){#F2}

![Localization and temporal expression of T cell-dependent factors in the infant intestinal tract. **(a)** Lamina propria CD4^+^ T cells densities were determined by immunohistochemistry (n = 14, 7, 10, 8, and 9 respectively from 0--1 mo to adult). Black lines indicate medians. *P*-values were determined using Kruskal-Wallis with Dunn's post-test. \*\* *P* \< .01 **(b)** CD4 and CD40L expression was determined by qPCR in infant intestinal tissues, ages ranging 0--6 months, in ILF-C (n=9) and LP-C (n=8) samples. **(c)** CD4, CD40L and CD40 mRNA expression in samples less than (\< 1mo; n=3) or greater than one month (\> 1mo; n=5--6). Bars indicate median with min and max values. *P*-values were determined using Mann-Whitney U test.](nihms515133f3){#F3}

![T cell-independent factor localization and temporal expression in the infant intestinal tract. **(a)** APRIL, BAFF and **(b)** their receptors TACI, BCMA and BAFF-R mRNA expression in ILF-C and LP-C samples was determined using qPCR. Samples were divided into age groups; less than 1 month of age (\< 1mo; n=3) or greater than one month (\> 1mo; n=5--6). Bars indicate median with min and max values. *P*-values were determined using Mann-Whitney U test. \* *P* \< .05. NS=not significant.](nihms515133f4){#F4}

![Relationship between cIgA^+^ cells, B cells and T cell-independent factors in the infant intestinal tract. Correlations of **(a)** APRIL and BMCA expression compared with cIgA^+^ cell densities and **(b)** TACI and BAFF-R compared with CD20 expression in ILF-C samples (n=9) using Spearman's rank correlation. Immunohistochemistry of APRIL (purple) and CD20 (black) within infant intestinal **(c--e)** isolated lymphoid follicles, **(e--f)** epithelium and **(f)** lamina propria. Yellow arrows indicate APRIL^+^ cells.](nihms515133f5){#F5}

![Effects of preterm birth on plasma cell development in the infant intestinal tract. **(a)** CD138^+^, cIgA^+^ and cIgM^+^ cell densities were compared using Mann-Whitney U test between preterm (n=5--6) and full term (n=8) infants with ages ranging from 1 and 6 months of age. **(b)** APRIL and BCMA mRNA expression levels in preterm (n=3) and full term infants (n=3). Infants with a gestational age of less than 36 weeks were considered preterm. Infants with a gestational age greater than 37 weeks were considered full term.](nihms515133f6){#F6}

###### 

Clinical characteristics of infant cohort; Denver, CO.

                                0--1 mo n = 21   1--2 mo n = 12\*   2--6 mo n = 17   6--24 mo n = 10   *P*-value
  ----------------------------- ---------------- ------------------ ---------------- ----------------- -----------
  **Age (days)**                12 (1--27)       47 (30--55)        89 (59--160)     489 (200--675)    \--
                                                                                                       
  **Gestational Age (weeks)**   37 (34--40)      37 (28--41)        37 (25--41)      37 (34--41)       0.3866
                                                                                                       
  **Sex**:                                                                                             
   Female                       62% (13)         50% (6)            35% (6)          50% (5)           0.4342
                                                                                                       
  **Mode of Delivery:**                                                                                
   Vaginal                      62% (13)         50% (6)            41% (7)          50% (5)           0.1658
   Cesarean                     24% (5)          33% (4)            12% (2)          10% (1)           
   Unknown                      14% (3)          17% (2)            47% (8)          40% (4)           
                                                                                                       
  **Reason for Biopsy**:                                                                               
   Constipation                 76% (16)         50% (6)            82% (14)         100% (10)         0.087
   Distension/other             24% (5)          42% (5)            18% (3)          0% (0)            
                                                                                                       
  **Breast fed**:                                                                                      
   Yes/in the past              67% (14)         75% (9)            88% (15)         60% (6)           0.1291
   No                           19% (4)          8% (1)             12% (2)          0% (0)            
   Unknown                      14% (3)          17% (2)            0% (0)           40% (4)           
                                                                                                       
  **Antibiotics:**                                                                                     
   Yes                          24% (5)          17% (2)            18% (3)          20% (2)           0.1439
   No                           57% (12)         17% (2)            29% (5)          20% (2)           
   Unknown                      19% (4)          67% (8)            53% (9)          60% (6)           

\-- Samples are stratified by age. For continuous variables, the median is followed by the range in parentheses. For categorical variables, percents are followed by frequency. \* no clinical data except age was available on one infant sample
